ESR1 and endometrial cancer: ESR1, mainly encoding the estrogen receptor, is closely associated with breast and endometrial cancers; many studies have reported that the estrogen receptor plays a crucial anti-GC role by arresting the cell cycle and inducing apoptosis, invasion, and migration (41–43).